23:40 , Jun 7, 2018 |  BC Innovations  |  Finance

Deerfield goes to school

Deerfield’s fourth umbrella agreement in the last eight months is a sign the firm is getting serious about creating newcos from academic discoveries. It thinks that with preset terms and unanimous buy-in, the model provides...
22:49 , Apr 3, 2018 |  BC Extra  |  Company News

Management tracks: Abeona, Dermavant, Assembly

Gene therapy play Abeona Therapeutics Inc. (NASDAQ:ABEO) said President and CEO Timothy Miller will transition to president and CSO. He is succeeded as CEO by Carsten Thiel, who was EVP and chief commercial officer at...
23:51 , Oct 19, 2017 |  BC Innovations  |  Finance

Broad umbrella

In its $50 million tie-up with the Broad Institute of MIT and Harvard , Deerfield Management is looking to forge a new mold of partnership with an academic organization that allows it to efficiently survey...
00:38 , Apr 28, 2017 |  BC Innovations  |  Finance

Hatching VC incubators

While more VCs have created venture incubators to nurture early concepts into full-fledged start-ups, they are aligned more on the need to incubate than on how best to do it. Indeed, a collection of VCs...
19:58 , Nov 4, 2016 |  BC Week In Review  |  Company News

Takeda, MSKCC, Rockefeller and Weill deal

Memorial Sloan Kettering Cancer Center, Rockefeller University and Weill Cornell Medical College launched Bridge Medicines, a drug discovery company designed to advance candidates developed at the partners' Tri-Institutional Therapeutics Discovery Institute Inc. (Tri-I TDI). The...
22:55 , Nov 2, 2016 |  BC Extra  |  Company News

N.Y. research group, Takeda launch newco Bridge

Memorial Sloan Kettering Cancer Center , Rockefeller University and Weill Cornell Medical College launched Bridge Medicines, a drug discovery company designed to advance candidates developed at the partners' Tri-Institutional Therapeutics Discovery Institute Inc. (Tri-I TDI)....